A Combined Lymphokine-activated Killer (LAK) Cell Immunotherapy and Adenovirus-p53 Gene Therapy for Head and Neck Squamous Cell Carcinoma | Anticancer Research
NK cells for cancer immunotherapy | Nature Reviews Drug Discovery
Cells | Free Full-Text | Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Cell-based immunotherapy
In this issue - 2020 - Cancer Science - Wiley Online Library
Selected clinical trials using lymphokine activated killer (LAK) cells. | Download Table
Effects of LAK cells against tumor cells. NKR-dependent and-independent... | Download Scientific Diagram
Frontiers | CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
LAK Cells Therapy - wincellresearch.com
Issels Immuno-Oncology - LAK Cell Therapy for the Treatment of Cancer
Natural Killer Cells | Oncohema Key
Cell-based immunotherapy
Innate or non-specific immunity
Establishment of Cell-to-Cell Contact by Adoptively Transferred Adherent Lymphokine-Activated Killer Cells With Metastatic Murin
Fig. S5: Characterization of lymphokine activated killer (LAK) cells... | Download Scientific Diagram
Cancers | Free Full-Text | Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells | PNAS
Advances in NK cell therapy for brain tumors | npj Precision Oncology
Isolation of Human NK Cells and Generation of LAK Activity - Whiteside - 1996 - Current Protocols in Immunology - Wiley Online Library
Activated autologous lymphocyte therapy | 免疫療法による癌（がん）治療｜株式会社リンフォテック
Effects of LAK cells against tumor cells. NKR-dependent and-independent... | Download Scientific Diagram
Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
Exercise-Dependent Regulation of NK Cells in Cancer Protection: Trends in Molecular Medicine
Antigen-independent killer cells prepared for adoptive immunotherapy: One source, divergent protocols, diverse nomenclature - ScienceDirect
![Figure 3 from [Study of adoptive immunotherapy with lymphokine-activated killer (LAK) cells and interleukin-2 for metastatic renal cell carcinoma. I. Generation of LAK cells by incubation in serum-free medium]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d775b75cf81322097286cf19a44783d9f22a7f04/5-Figure3-1.png "Figure 3 from [Study of adoptive immunotherapy with lymphokine-activated killer (LAK) cells and interleukin-2 for metastatic renal cell carcinoma. I. Generation of LAK cells by incubation in serum-free medium]. | Semantic Scholar")
Figure 3 from [Study of adoptive immunotherapy with lymphokine-activated killer (LAK) cells and interleukin-2 for metastatic renal cell carcinoma. I. Generation of LAK cells by incubation in serum-free medium]. | Semantic Scholar
Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells | PNAS
Evolution of cell therapy for renal cell carcinoma | Molecular Cancer | Full Text
LAK cell engaging a cancer cell - Stock Image - M132/0313 - Science Photo Library
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1 - ScienceDirect
